Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$15.84
-2.88%
Mkt Cap $1.44B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$22.00
Range $19.00 – $28.00
Implied Upside
+38.9%
Consensus $22.00 vs current $15.84
NASDAQ·Healthcare·Biotechnology
$15.84
-2.88%
Mkt Cap $1.44B
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$22.00
Range $19.00 – $28.00
+38.9%
Consensus $22.00 vs current $15.84